Navigation Links
Lilly Announces Acquisition of CGRP Antibody for Migraine Prevention from Arteaus Therapeutics
Date:1/13/2014

INDIANAPOLIS, Jan. 13, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that, based on positive Phase 2 data, it has acquired all development rights for a calcitonin gene-related peptide (CGRP) antibody currently being studied as a potential treatment for the prevention of frequent, recurrent migraine headaches. CGRP is a sensory neuropeptide with vascular and pro-inflammatory effects, two processes that have been implicated in migraine headaches. Lilly's CGRP antibody is a biologic entity injected subcutaneously that binds and inhibits the activity of CGRP, which is released during activation of sensory neurons involved in pain signaling.

This novel molecule (LY2951742) was discovered by Lilly scientists and then licensed to Arteaus Therapeutics for development in the clinical proof-of-concept study. Financial terms of the deal were not disclosed.

Arteaus was formed in 2011 with an $18 million investment from Atlas Venture and OrbiMed, upon acquiring the rights to develop Lilly's CGRP antibody. Licensing Lilly's CGRP antibody to Arteaus was part of Lilly's alternative risk-sharing strategy, which includes participation in the Capital Funds Portfolio. The Capital Funds Portfolio comprises virtual project-focused companies, financed by independent investment funds that acquire early-stage molecules to develop through proof-of-concept (one or more clinical studies designed to determine whether a molecule has the potential to work in patients). If the molecule shows efficacy, the molecule and/or development rights are offered for sale to biopharmaceutical companies.

"Of the nine project-focused companies currently in the Capital Funds Portfolio, Arteaus is the first to reach proof-of-concept and to achieve positive results. Through this strategy, independent investment firms and portfolio companies provide a unique way
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. DiversityInc Names Lilly a Top Company for Diversity
2. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
3. Lilly Sets Date for Lilly Diabetes Pipeline Update to the Investment Community
4. Lilly Applauds Law Enforcement Officials for their Successful Investigation and Recovery of Pharmaceuticals Stolen from Connecticut Distribution Center
5. Lilly Oncology To Disclose New Pipeline Data At ASCO 2012
6. Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting
7. Lilly and Incytes Oral JAK1 and JAK2 Inhibitor, Baricitinib, Showed Positive Results in Phase IIb Study in Patients with Active Rheumatoid Arthritis
8. Lilly and Boehringer Ingelheim Present Data at the 72nd American Diabetes Association Scientific Sessions® from Phase II Studies Comparing Investigational Novel Basal Insulin to Insulin Glargine
9. Lilly Expands Strategic Partnership with Chinese Manufacturer Novast to Serve Chinese Patients with High-Quality Branded Generic Medicines
10. Lilly Diabetes Launches 8th Annual Diabetes Summer Camp Tour With Olympian Kris Freeman
11. Lilly Declares Third-Quarter 2012 Dividend, Resumes Share Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... 2015 Research and ... of the "Investigation Report on China,s Quetiapine ... Developed by AstraZeneca plc, quetiapine (under the ... for the treatment of schizophrenia. Approved by CFDA ... in the Catalogue of Drugs for the Basic ...
(Date:8/28/2015)... , Aug. 28, 2015 ... addition of the "Investigation Report on China,s Ranibizumab ... Developed by Novartis, ranibizumab was approved by CFDA to ... Currently, only Lucentis, a product of Novartis, is available ... the first self- developed drug for the treatment of ...
(Date:8/28/2015)... Perrigo Company plc ("Perrigo") (NYSE: PRGO ; TASE) ... MYL ) shareholder vote regarding its planned unsolicited offer ... offer to Perrigo shareholders have always been, and will ... of the value available to Perrigo shareholders, and do ... allowed its shareholders to consider," said Joseph C. ...
Breaking Medicine Technology:China Quetiapine Market Investigation Report 2010-2019 2Investigation Report on China's Ranibizumab Market, 2012-2019 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 3Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 4Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 5
... Pharmaceuticals (Nasdaq: ENDP ) announced today the ... President, HealthTronics Inc., effective Aug. 29, 2011. HealthTronics, an ... products and services based in Austin, Texas. ... Group President James Whittenburg, who is staying through the ...
... Aug. 22, 2011 Leatt Corporation, a Nevada corporation ... Leatt-Brace®, a Neck Brace System designed to help prevent ... (neck), as well as other products, today announced that ... Department of Commerce issued a patent for the Leatt ...
Cached Medicine Technology:Endo Pharmaceuticals Announces Leadership Change at HealthTronics Subsidiary: Appoints Kelly Huang, Ph.D. New President 2Endo Pharmaceuticals Announces Leadership Change at HealthTronics Subsidiary: Appoints Kelly Huang, Ph.D. New President 3U.S. Patent for Leatt Neck Brace System Issued 2
(Date:8/28/2015)... ... August 28, 2015 , ... With the goal of furthering ... the second year to the Adams County Fairgrounds in Mendon, IL on May 30th, ... money to support music education in the underfunded school districts of Mendon and its ...
(Date:8/28/2015)... ... 28, 2015 , ... The 6th Annual Survivor in the City, Chicago ... yet another accolade to its cadre of widespread support—an official letter of support and ... of the medical community and the University of Illinois at Chicago’s Department of Neurosurgery, ...
(Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... “ Frequentz ... look at the latest and coolest applications on the market for iOS, Android, and ... and shared with viewers how this software allows businesses to track product movement from ...
(Date:8/28/2015)... TN (PRWEB) , ... August 28, 2015 , ... ... recipients of the Veterans Award, honoring military veterans leading in business. Mr. ... honorees. , The inaugural Nashville Business Journal's 2015 Veterans Awards will ...
(Date:8/28/2015)... ... August 28, 2015 , ... The Quatela Center for Plastic Surgery ... first and only nonsurgical product approved by the Food and Drug Administration to eliminate ... and Dr. William Koenig are among the premier cosmetic surgeons in Rochester ...
Breaking Medicine News(10 mins):Health News:Best Drug Rehabilitation Interviews Country-Rock Duo Highway Run at the 2015 "Music With A Mission" Benefit Concert 2Health News:Chicago Mayor Pens Official Support of Annual Survivor in the City Event Benefitting Brain Aneurysm Foundation 2Health News:Chicago Mayor Pens Official Support of Annual Survivor in the City Event Benefitting Brain Aneurysm Foundation 3Health News:Track Product Movement from Beginning to End with Frequentz 2Health News:MyGenetx Board Member Receives Veterans Award 2Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 2Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 3
... FAIRFAX, Va., June 9 General Dynamics,Information Technology, ... GD ), has,been awarded three task orders by ... Support Wholesale Program (DMLSS-W). The,contracts have a total ... if,all options are exercised., Under these tasks, ...
... cancer are being failed by medical researchers who are ... in mind and who are not recruiting sufficient numbers ... according to new figures announced today (Monday). , Dr ... Cancer Trust,s Fifth International Conference on Teenage and Young ...
... 2008 A 115-year-old woman who remained mentally alert ... little or no evidence of Alzheimer,s disease, according to ... Aging ( http://neurobiologyofaging.org/ ). , The findings question the ... will inevitably develop, if people live long enough. ...
... patients who attended a specialist nurse clinic rather than ... longer, more frequent consultations and good symptom management, according ... Journal of Clinical Nursing. , And because the ... per cent of the consultations without referring issues to ...
... WASHINGTON, June 9 Gentag, Inc. and MacroArray,Technologies, ... design a,wireless immunoassay incorporating Gentag,s cell phone communication,technology ... One in six males are at risk ... are being tested. In order to simplify and ...
... June 9 ATS Medical, Inc.,(Nasdaq: ... cardiac,surgery products and services, today noted that ... experience with ATS Medical products and related,procedures ... International,Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) ...
Cached Medicine News:Health News:General Dynamics Awarded Multiple Contracts to Support Defense Medical Logistics Supply Chain Operations 2Health News:Organizers of cancer clinical trials are neglecting teenagers and young adults 2Health News:Organizers of cancer clinical trials are neglecting teenagers and young adults 3Health News:World's oldest woman had normal brain 2Health News:Specialist nurses can play a key role in supporting patients having radiotherapy 2Health News:Specialist nurses can play a key role in supporting patients having radiotherapy 3Health News:Gentag, Inc. and MacroArray Technologies Join Forces 2Health News:ATS Medical Products Prominently Featured in International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) Scientific Presentations 2Health News:ATS Medical Products Prominently Featured in International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) Scientific Presentations 3
... Studies have proven that the management of ... blood glucose levels is the most effective way ... comprehensive care aimed at maintaining or improving a ... complex and costly. , ,These have been ...
... diabetes requires making decisions about insulin dosages ... These decisions are guided by data from ... and by the patterns that can be ... Providers when the data is presented in ...
... Diode Pumped Green Photocoagulator - Portable and ... hospital outpatient clinic, and operating room. Built ... even in the most demanding environments, the ... needs. A full line of accessories ...
The ring maintains the bag tension avoiding the development of posterior capsule pleats. It is also established to compensate the efforts induced during the bag retraction....
Medicine Products: